Analyst Research: Johnson & Johnson (JNJ)

JNJ on New York Consolidated

101.09USD
15 Aug 2014
Price Change (% chg)

$-0.93 (-0.91%)
Prev Close
$102.02
Open
$102.21
Day's High
$102.44
Day's Low
$100.80
Volume
6,986,145
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - JOHNSON & JOHNSON (JNJ-N) 19 Aug 2014 Thomson Reuters Stock Report 12 25.00
Trading Report for (JNJ). A detailed report, including free correlated market analysis, and updates. 19 Aug 2014 Stock Traders Daily 10 20.00
JNJ: Due Diligence Review: Forensic Earnings and Valuation 18 Aug 2014 New Constructs, LLC 9 25.00
"The Economy Matters" Report for JNJ: the economy's impact on JNJ's price and risk, featuring the powerful Economic Climate Rating 18 Aug 2014 MacroRisk Analytics/EconomicInvestor 7 25.00
ValuEngine Rating and Forecast Report for JNJ 17 Aug 2014 ValuEngine, Inc. 11 25.00
Wright Investors Service Comprehensive Report for Johnson & Johnson 17 Aug 2014 Wright Reports 57 75.00
Johnson & Johnson 16 Aug 2014 S&P Capital IQ – STARS Reports 11 127.00
Our Economy without Stimulus; forward observations. 15 Aug 2014 Stock Traders Daily 102 20.00
JOHNSON JOHNSON (JNJ) - REPORT FOR ACTIVE TRADERS 15 Aug 2014 Pechala's Reports 1 25.00
JOHNSON JOHNSON (JNJ) 12-months forecast 15 Aug 2014 Pechala's Reports 1 15.00
 
Name Age Since Current Position

Alex Gorsky

54 2012 Chairman of the Board, Chief Executive Officer

Dominic Caruso

56 2007 Chief Financial Officer, Vice President - Finance

Sandra Peterson

55 2012 Group Worldwide Chairman

Paulus Stoffels

52 2012 Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group

Michael Ullmann

55 2012 Vice President, General Counsel
Search Stocks